相关实验视频

Updated: Jan 18, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

在EQUAL研究中通过g-formula分析对CKD-MBD生物标志物变化的CKD进展的因果评估

Lorenza Magagnoli¹, Mario Cozzolino², Fergus J Caskey³

¹Department of Health Sciences, University of Milan, Milan, Italy; ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, The Netherlands.

Kidney international

|September 11, 2025

概括

在晚期慢性病 (CKD) 的老年患者中,高酸盐和副甲状腺激素水平,特别是与低相结合,显著加快CKD的进展并增加透析风险.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
内分泌学在内分泌学.
老年病的医生老年病的医生

背景情况:

慢性病-矿物质和骨疾病 (CKD-MBD) 与CKD进展有关.
了解晚期CKD中矿物质和骨疾病生物标志物至关重要.

研究的目的:

研究酸盐,甲状腺类激素和对CKD进展的影响.
评估这些生物标志物对EGFR下降和透析风险的综合影响.
探索这些关联中的基于性别的差异.

主要方法:

利用了来自欧洲质量研究的1709名老年参与者的数据 (≥65岁),其eGFR≤20毫升/分钟/1.73平方米.
使用因果推理的g公式来解决来自审查和混的偏见.
分析了生物标志物和临床结果的纵向变化.

主要成果:

孤立的高酸血症和甲状腺功能障碍症增加了CKD进展风险;孤立的高血症没有.
高酸血症/低血症与甲状腺功能障碍症的组合显著增加了风险.
高酸血症,低血症和甲状腺功能障碍症的表型显示出最严重的不良影响,平均EGFR下降为-3.71毫升/分钟,透析风险提高了75%.
超酸血是风险的主要驱动因素.
男性的透析风险似乎比女性高,尽管eGFR的下降程度相似.

结论:

在患有晚期CKD的老年人中,高酸血症,特别是低血症和甲状腺功能障碍症,显著增加CKD进展风险.
这些发现凸显了矿物质失调在晚期病中的关键作用.
针对矿物质不平衡的干预措施可能对控制CKD进展至关重要.

关键词:

慢性结核病的进展情况在 CKD-MBD 中.PTHTH PTH 这是一个很好的方法.和是最重要的.透析是通过透析进行的.酸盐酸盐的使用方法

更多相关视频

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

相关概念视频

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...